Table 2.

Comparing the anthropometric and biochemical parameters before and after 16 weeks treatment

	Placebo				Cabergoline
	Before	After 16 w	p-value	95% CI	Before	After 16 w	p-value	95% CI
Sex (M/F)	4/10	4/7			7/6	7/5
Prolactin (ng/mL)	9.65 ± 0.87	9.78 ± 1.01	0.92	-2.91 — 2.65	10.23 ± 1.86	0.29 ± 0.08	0.00	6.09 — 13.85
BMI (Kg/m2)	27.50 ± 1.21	26.83 ± 1.20	0.70	-2.98 — 4.35	30.67 ± 1.54	29.77 ± 1.42	0.67	-3.46 — 5.26
A1c (%)	5.70 ± 0.08	5.77 ± 0.10	0.64	-0.34 — 0.21	5.7 ± 0.13	5.59 ± 0.01	0.46	-0.20 — 0.43
Weight (Kg)	73.90 ± 4.35	72.18 ± 4.56	0.78	-11.43 — 14.89	81.41 ± 4.51	79.00 ± 4.16	0.69	-10.31 — 15.41
WC* (cm)	95.72 ± 3.5	92.36 ± 3.89	0.52	-7.56 — 14.29	104.75 ± 3.29	102.33 ± 3.44	0.61	-7.47 — 12.31
2h Insulin (µU/L)	66.22 ± 9.35	51.14 ± 10.48	0.30	N.NL.	77.32 ± 3.75	55.23 ± 7.79	0.02	2.84 — 4.34
HOMA2 %B	96.26 ± 17.36	80.90 ± 9.53	0.46	-27.30 — 58.02	85.63 ± 5.44	98.65 ± 6.06	0.12	-29.93 — 3.88
HOMA2 %S	101.16 ± 19.98	109.65 ± 22.91	0.78	-71.91 — 54.93	76.76 ± 7.24	98.65 ± 6.06	0.03	-41.40 — -2.28
HOMA2 IR	1.54 ± 0.33	1.40 ± 0.27	0.74	-0.76 — 1.05	1.46 ± 0.14	1.14 ± 0.04	0.04	0.00 — 0.64

Value represented as mean ± SEM

Bolded P values are statistically different before and after 16 weeks of treatment

Analysis done based on within group average changed over 16 weeks

^*Waist Circumferences (WC)